//ads.jademaple.com/www/delivery/asyncjs.php

Health

Using Cannabinoids to Treat Zika Virus Symptoms

·
TORONTO, May 16, 2017 /CNW/ - Alternate Health Corp. (CSE:AHG, OTC:AHGIF), a diverse healthcare company revolutionizing patient care and research through compliance and technology in the emerging medical cannabis industry, announced today the completion of its initial study to demonstrate the effectiveness of cannabinoid in treating chronic post-Zika virus symptoms.
BusinessFeaturedHealthMarijuana NewsPress ReleasesScienceTechnology
·0 Comments·

Medical Cannabis Effective for Opioid Addiction

·
SCRANTON, Pa., April 24, 2017 /PRNewswire/ -- Scranton law firm The Slocum Firm, PC, today released a white paper entitled "The Utilization of Cannabis for Pain Relief and Opioid Addiction," aimed at policy makers, medical providers, and thought leaders. The report discusses the serious individual and public-health problems caused by opioid addiction, and it examines research showing that marijuana is a promising treatment for people addicted to prescription opioid painkillers.
HealthLawMarijuana NewsPress ReleasesScience
·1 Comment·

Government Duplicit on Cannabis

·
NEW YORK, April 20, 2017 /PRNewswire/ -- Alexander Nachman, "The Pitbull of Pot" and one of the nation's leading experts on the medicinal, social and economic benefits of legalizing cannabis, wrote a pointed and satirical piece about the government's refusal to acknowledge that cannabis has medicinal value, while they secretly own patent rights on the synthetic versions of the plant. The piece is printed in CannaNews.Buzz, a prominent publication covering the legal marijuana industry.
BusinessHealthMarijuana NewsPoliticsPress Releases
·0 Comments·

GB Sciences Submits Offer to Louisiana State University for Medical Cannabis

·
LAS VEGAS, April 3, 2017 /PRNewswire/ -- GB Sciences, Inc. (formerly known as Growblox Sciences, Inc.) (OTCQB: GBLX) submits offer to Louisiana State University (LSU) to act as the LSU licensed operator of their medical cannabis production facility as outlined in the Alison Neustrom Act (hereinafter referred to as the "Act"). The offer would enable GB Sciences to be the sole vendor of cannabis and extracted cannabis compounds on behalf of LSU for the patients of Louisiana. LSU and Southern University have the only two licenses granted by the State of Louisiana to cultivate, distribute, and sell medical cannabis.
BusinessHealthPress ReleasesScience
·0 Comments·